0IV3.L
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company's product pipeline includes RYTELO, a telomerase inhibitor for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia; IMerge which is in Phase 3 clinical trial for the treatment of lower-risk myelodysplastic syndromes; IMpactMF that is in Phase 3 for the treatment of relapsed/refractory myelofibrosis; Impress which is in Phase 2 clinical trial to treat higher risk myelodysplastic syndromes and acute myeloid leukemia (AML); IMproveMF which is in Phase 1 clinical trial for the treatm...[Read more]
Industry
Biotechnology
IPO Date
2018-01-29
Stock Exchange
LSE
Ticker
0IV3.L
According to Geron Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -12.61. This represents a change of -50.93% compared to the average of -25.70 of the last 4 quarters.
The mean historical PE Ratio of Geron Corporation over the last ten years is -7.71. The current -12.61 PE Ratio has changed 16.26% with respect to the historical average. Over the past ten years (40 quarters), 0IV3.L's PE Ratio was at its highest in in the December 2019 quarter at -2.27. The PE Ratio was at its lowest in in the March 2026 quarter at -68.98.
Average
-7.71
Median
-6.63
Minimum
-13.11
Maximum
-3.30
Discovering the peaks and valleys of Geron Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 98.84%
Maximum Annual PE Ratio = -3.30
Minimum Annual Increase = -100.07%
Minimum Annual PE Ratio = -13.11
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -10.15 | -22.56% |
| 2024 | -13.11 | 98.84% |
| 2023 | -6.59 | 0.81% |
| 2022 | -6.54 | 98.36% |
| 2021 | -3.30 | -41.93% |
| 2020 | -5.68 | 37.79% |
| 2019 | -4.12 | -38.18% |
| 2018 | -6.67 | -33.33% |
| 2017 | -10.00 | -8.21% |
| 2016 | -10.89 | -100.07% |
The current PE Ratio of Geron Corporation (0IV3.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-9.95
5-year avg
-7.94
10-year avg
-7.71
Geron Corporation’s PE Ratio is less than Iovance Biotherapeutics, Inc. (-5.07), less than Anavex Life Sciences Corp. (-5.05), less than Myriad Genetics, Inc. (-1.44), greater than Esperion Therapeutics, Inc. (-131.40), greater than Axogen, Inc. (-62.92), less than Verastem, Inc. (-2.31), greater than Emergent BioSolutions Inc. (-45.24), less than Nektar Therapeutics (-7.96), less than OPKO Health, Inc. (-4.32), less than Editas Medicine, Inc. (-2.35),
| Company | PE Ratio | Market cap |
|---|---|---|
| -5.07 | N/A | |
| -5.05 | N/A | |
| -1.44 | N/A | |
| -131.40 | N/A | |
| -62.92 | N/A | |
| -2.31 | N/A | |
| -45.24 | N/A | |
| -7.96 | N/A | |
| -4.32 | N/A | |
| -2.35 | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Geron Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Geron Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Geron Corporation's PE Ratio?
How is the PE Ratio calculated for Geron Corporation (0IV3.L)?
What is the highest PE Ratio for Geron Corporation (0IV3.L)?
What is the 3-year average PE Ratio for Geron Corporation (0IV3.L)?
What is the 5-year average PE Ratio for Geron Corporation (0IV3.L)?
How does the current PE Ratio for Geron Corporation (0IV3.L) compare to its historical average?